{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T17:04:25Z","timestamp":1794848665814,"version":"4.9.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Neurosci"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1038\/s41593-025-02103-0","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T10:17:00Z","timestamp":1762424220000},"page":"81-87","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Microglia modulate A\u03b2-dependent astrocyte reactivity in Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2183-1551","authenticated-orcid":false,"given":"Jo\u00e3o Pedro","family":"Ferrari-Souza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2023-6569","authenticated-orcid":false,"given":"Guilherme","family":"Povala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesrine","family":"Rahmouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2212-3373","authenticated-orcid":false,"given":"Bruna","family":"Bellaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2134-9829","authenticated-orcid":false,"given":"Pamela C. L.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Ant\u00f4nio","family":"De Bastiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4890-8451","authenticated-orcid":false,"given":"Douglas T.","family":"Leffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firoza Z.","family":"Lussier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7378-3830","authenticated-orcid":false,"given":"Cristiano S.","family":"Aguzzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wagner S.","family":"Brum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Carello-Collar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wyllians V.","family":"Borelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Therriault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur C.","family":"Macedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stijn","family":"Servaes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Pola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Gauthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diogo O.","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas Porcello","family":"Schilling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1078-0296","authenticated-orcid":false,"given":"Mychael V.","family":"Lourenco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gallen","family":"Triana-Baltzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmuth C.","family":"Kolb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9a L.","family":"Benedet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Ashton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana L.","family":"Tudorascu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3930-4354","authenticated-orcid":false,"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1890-4193","authenticated-orcid":false,"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8501-545X","authenticated-orcid":false,"given":"Sterling C.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9057-8014","authenticated-orcid":false,"given":"Tharick A.","family":"Pascoal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9116-1376","authenticated-orcid":false,"given":"Pedro","family":"Rosa-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5349-0053","authenticated-orcid":false,"given":"Eduardo R.","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"2103_CR1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","volume":"7","author":"DS Knopman","year":"2021","unstructured":"Knopman, D. S. et al. Alzheimer disease. Nat. Rev. Dis. Primers 7, 33 (2021).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"2103_CR2","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/nn.4017","volume":"18","author":"K Herrup","year":"2015","unstructured":"Herrup, K. The case for rejecting the amyloid cascade hypothesis. Nat. Neurosci. 18, 794\u2013799 (2015).","journal-title":"Nat. Neurosci."},{"key":"2103_CR3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.molmed.2018.11.006","volume":"25","author":"SF Carter","year":"2019","unstructured":"Carter, S. F. et al. Astrocyte biomarkers in Alzheimer\u2019s disease. Trends Mol. Med. 25, 77\u201395 (2019).","journal-title":"Trends Mol. Med."},{"key":"2103_CR4","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka, M. T. et al. Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. 14, 388\u2013405 (2015).","journal-title":"Lancet Neurol."},{"key":"2103_CR5","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41593-020-00783-4","volume":"24","author":"C Escartin","year":"2021","unstructured":"Escartin, C. et al. Reactive astrocyte nomenclature, definitions, and future directions. Nat. Neurosci. 24, 312\u2013325 (2021).","journal-title":"Nat. Neurosci."},{"key":"2103_CR6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0006-8993(97)01318-8","volume":"785","author":"J Hu","year":"1998","unstructured":"Hu, J., Akama, K. T., Krafft, G. A., Chromy, B. A. & Van Eldik, L. J. Amyloid-\u03b2 peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release. Brain Res. 785, 195\u2013206 (1998).","journal-title":"Brain Res."},{"key":"2103_CR7","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0165-5728(98)00226-4","volume":"93","author":"M Johnstone","year":"1999","unstructured":"Johnstone, M., Gearing, A. J. & Miller, K. M. A central role for astrocytes in the inflammatory response to \u03b2-amyloid; chemokines, cytokines and reactive oxygen species are produced. J. Neuroimmunol. 93, 182\u2013193 (1999).","journal-title":"J. Neuroimmunol."},{"key":"2103_CR8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.pneurobio.2016.01.001","volume":"144","author":"LM Osborn","year":"2016","unstructured":"Osborn, L. M., Kamphuis, W., Wadman, W. J. & Hol, E. M. Astrogliosis: an integral player in the pathogenesis of Alzheimer\u2019s disease. Prog. Neurobiol. 144, 121\u2013141 (2016).","journal-title":"Prog. Neurobiol."},{"key":"2103_CR9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow, S. A. et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541, 481\u2013487 (2017).","journal-title":"Nature"},{"key":"2103_CR10","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1038\/s41591-023-02380-x","volume":"29","author":"B Bellaver","year":"2023","unstructured":"Bellaver, B. et al. Astrocyte reactivity influences amyloid-\u03b2 effects on tau pathology in preclinical Alzheimer\u2019s disease. Nat. Med. 29, 1775\u20131781 (2023).","journal-title":"Nat. Med."},{"key":"2103_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/jcbfm.2011.147","volume":"32","author":"DR Owen","year":"2012","unstructured":"Owen, D. R. et al. An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28. J. Cereb. Blood Flow Metab. 32, 1\u20135 (2012).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"2103_CR12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/bpa.12763","volume":"30","author":"Y Gui","year":"2020","unstructured":"Gui, Y., Marks, J. D., Das, S., Hyman, B. T. & Serrano-Pozo, A. Characterization of the 18 kDa translocator protein (TSPO) expression in post-mortem normal and Alzheimer\u2019s disease brains. Brain Pathol. 30, 151\u2013164 (2020).","journal-title":"Brain Pathol."},{"key":"2103_CR13","doi-asserted-by":"crossref","unstructured":"Jack, C. R. Jr et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimers Dement. 20, 5143\u20135169 (2024).","DOI":"10.1002\/alz.13859"},{"key":"2103_CR14","doi-asserted-by":"crossref","first-page":"6797","DOI":"10.1523\/JNEUROSCI.3351-16.2017","volume":"37","author":"LP Diniz","year":"2017","unstructured":"Diniz, L. P. et al. Astrocyte transforming growth factor beta 1 protects synapses against A\u03b2 oligomers in Alzheimer\u2019s disease model. J. Neurosci. 37, 6797\u20136809 (2017).","journal-title":"J. Neurosci."},{"key":"2103_CR15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13024-021-00487-8","volume":"16","author":"P Preman","year":"2021","unstructured":"Preman, P. et al. Human iPSC-derived astrocytes transplanted into the mouse brain undergo morphological changes in response to amyloid-\u03b2 plaques. Mol. Neurodegener. 16, 68 (2021).","journal-title":"Mol. Neurodegener."},{"key":"2103_CR16","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.ajpath.2011.05.047","volume":"179","author":"A Serrano-Pozo","year":"2011","unstructured":"Serrano-Pozo, A. et al. Reactive glia not only associates with plaques but also parallels tangles in Alzheimer\u2019s disease. Am. J. Pathol. 179, 1373\u20131384 (2011).","journal-title":"Am. J. Pathol."},{"key":"2103_CR17","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1001\/jamaneurol.2021.3671","volume":"78","author":"AL Benedet","year":"2021","unstructured":"Benedet, A. L. et al. Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the Alzheimer disease continuum. JAMA Neurol. 78, 1471\u20131483 (2021).","journal-title":"JAMA Neurol."},{"key":"2103_CR18","doi-asserted-by":"crossref","unstructured":"Ferrari-Souza, J. P. et al. Astrocyte biomarker signatures of amyloid-\u03b2 and tau pathologies in Alzheimer\u2019s disease. Mol. Psychiatry 27, 4781\u22124789 (2022).","DOI":"10.1038\/s41380-022-01716-2"},{"key":"2103_CR19","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.3389\/fimmu.2020.01416","volume":"11","author":"A Matejuk","year":"2020","unstructured":"Matejuk, A. & Ransohoff, R. M. Crosstalk between astrocytes and microglia: an overview. Front. Immunol. 11, 1416 (2020).","journal-title":"Front. Immunol."},{"key":"2103_CR20","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1038\/s41593-024-01791-4","volume":"27","author":"A Serrano-Pozo","year":"2024","unstructured":"Serrano-Pozo, A. et al. Astrocyte transcriptomic changes along the spatiotemporal progression of Alzheimer\u2019s disease. Nat. Neurosci. 27, 2384\u20132400 (2024).","journal-title":"Nat. Neurosci."},{"key":"2103_CR21","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41593-018-0290-2","volume":"22","author":"C Bottcher","year":"2019","unstructured":"Bottcher, C. et al. Human microglia regional heterogeneity and phenotypes determined by multiplexed single-cell mass cytometry. Nat. Neurosci. 22, 78\u201390 (2019).","journal-title":"Nat. Neurosci."},{"key":"2103_CR22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41593-019-0560-7","volume":"23","author":"L Kodama","year":"2020","unstructured":"Kodama, L. et al. Microglial microRNAs mediate sex-specific responses to tau pathology. Nat. Neurosci. 23, 167\u2013171 (2020).","journal-title":"Nat. Neurosci."},{"key":"2103_CR23","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1093\/brain\/awac257","volume":"145","author":"KB Casaletto","year":"2022","unstructured":"Casaletto, K. B. et al. Sex-specific effects of microglial activation on Alzheimer\u2019s disease proteinopathy in older adults. Brain 145, 3536\u20133545 (2022).","journal-title":"Brain"},{"key":"2103_CR24","doi-asserted-by":"crossref","unstructured":"Fumagalli, L. et al. Microglia heterogeneity, modeling and cell-state annotation in development and neurodegeneration. Nat. Neurosci. 28, 1381\u22121392 (2025).","DOI":"10.1038\/s41593-025-01931-4"},{"key":"2103_CR25","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2011.50","volume":"2","author":"CJ Garwood","year":"2011","unstructured":"Garwood, C. J., Pooler, A. M., Atherton, J., Hanger, D. P. & Noble, W. Astrocytes are important mediators of A\u03b2-induced neurotoxicity and tau phosphorylation in primary culture. Cell Death Dis. 2, e167 (2011).","journal-title":"Cell Death Dis."},{"key":"2103_CR26","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/s41593-020-00728-x","volume":"23","author":"K Richetin","year":"2020","unstructured":"Richetin, K. et al. Tau accumulation in astrocytes of the dentate gyrus induces neuronal dysfunction and memory deficits in Alzheimer\u2019s disease. Nat. Neurosci. 23, 1567\u20131579 (2020).","journal-title":"Nat. Neurosci."},{"key":"2103_CR27","doi-asserted-by":"crossref","unstructured":"Mann, C. N. et al. Astrocytic \u03b12-Na+\/K+ ATPase inhibition suppresses astrocyte reactivity and reduces neurodegeneration in a tauopathy mouse model. Sci. Transl. Med. 14, eabm4107 (2022).","DOI":"10.1126\/scitranslmed.abm4107"},{"key":"2103_CR28","volume":"15","author":"SC Hopp","year":"2018","unstructured":"Hopp, S. C. et al. The role of microglia in processing and spreading of bioactive tau seeds in Alzheimer\u2019s disease. J. Neuroinflammation 15, 269 (2018).","journal-title":"J. Neuroinflammation"},{"key":"2103_CR29","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","volume":"575","author":"C Ising","year":"2019","unstructured":"Ising, C. et al. NLRP3 inflammasome activation drives tau pathology. Nature 575, 669\u2013673 (2019).","journal-title":"Nature"},{"key":"2103_CR30","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1093\/brain\/awz241","volume":"142","author":"R Mancuso","year":"2019","unstructured":"Mancuso, R. et al. CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice. Brain 142, 3243\u20133264 (2019).","journal-title":"Brain"},{"key":"2103_CR31","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/alz.13539","volume":"20","author":"PM Cogswell","year":"2024","unstructured":"Cogswell, P. M. et al. Modeling the temporal evolution of plasma p-tau in relation to amyloid beta and tau PET. Alzheimers Dement. 20, 1225\u20131238 (2024).","journal-title":"Alzheimers Dement."},{"key":"2103_CR32","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1038\/s41591-021-01456-w","volume":"27","author":"TA Pascoal","year":"2021","unstructured":"Pascoal, T. A. et al. Microglial activation and tau propagate jointly across Braak stages. Nat. Med. 27, 1592\u20131599 (2021).","journal-title":"Nat. Med."},{"key":"2103_CR33","first-page":"1797","volume":"28","author":"M Mila-Aloma","year":"2022","unstructured":"Mila-Aloma, M. et al. Plasma p-tau231 and p-tau217 as state markers of amyloid-\u03b2 pathology in preclinical Alzheimer\u2019s disease. Nat. Med. 28, 1797\u20131801 (2022).","journal-title":"Nat. Med."},{"key":"2103_CR34","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz2387","volume":"6","author":"N Mattsson-Carlgren","year":"2020","unstructured":"Mattsson-Carlgren, N. et al. A\u03b2 deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer\u2019s disease. Sci. Adv. 6, eaaz2387 (2020).","journal-title":"Sci. Adv."},{"key":"2103_CR35","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/jamaneurol.2020.4201","volume":"78","author":"S Janelidze","year":"2021","unstructured":"Janelidze, S. et al. Associations of plasma phospho-tau217 levels with tau positron emission tomography in early Alzheimer disease. JAMA Neurol. 78, 149\u2013156 (2021).","journal-title":"JAMA Neurol."},{"key":"2103_CR36","doi-asserted-by":"crossref","unstructured":"Therriault, J. et al. Association of phosphorylated tau biomarkers with amyloid positron emission tomography vs tau positron emission tomography. JAMA Neurol. 80, 188\u2212199 (2022).","DOI":"10.1001\/jamaneurol.2022.4485"},{"key":"2103_CR37","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114022","volume":"13","author":"N Mattsson-Carlgren","year":"2021","unstructured":"Mattsson-Carlgren, N. et al. Soluble P-tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau. EMBO Mol. Med. 13, e14022 (2021).","journal-title":"EMBO Mol. Med."},{"key":"2103_CR38","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-34129-4","volume":"13","author":"A Pichet Binette","year":"2022","unstructured":"Pichet Binette, A. et al. Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer\u2019s disease. Nat. Commun. 13, 6635 (2022).","journal-title":"Nat. Commun."},{"key":"2103_CR39","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1093\/brain\/awaa180","volume":"143","author":"TA Pascoal","year":"2020","unstructured":"Pascoal, T. A. et al. 18F-MK-6240 PET for early and late detection of neurofibrillary tangles. Brain 143, 2818\u20132830 (2020).","journal-title":"Brain"},{"key":"2103_CR40","doi-asserted-by":"crossref","unstructured":"La Joie, R. et al. Prospective longitudinal atrophy in Alzheimer\u2019s disease correlates with the intensity and topography of baseline tau-PET. Sci. Transl. Med. 12, eaau5732 (2020).","DOI":"10.1126\/scitranslmed.aau5732"},{"key":"2103_CR41","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1038\/s41591-022-02049-x","volume":"28","author":"R Ossenkoppele","year":"2022","unstructured":"Ossenkoppele, R. et al. Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline. Nat. Med. 28, 2381\u20132387 (2022).","journal-title":"Nat. Med."},{"key":"2103_CR42","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1365-2990.2008.01006.x","volume":"35","author":"M Cosenza-Nashat","year":"2009","unstructured":"Cosenza-Nashat, M. et al. Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain. Neuropathol. Appl. Neurobiol. 35, 306\u2013328 (2009).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"2103_CR43","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/NEN.0b013e318188b204","volume":"67","author":"S Venneti","year":"2008","unstructured":"Venneti, S., Wang, G., Nguyen, J. & Wiley, C. A. The positron emission tomography ligand DAA1106 binds with high affinity to activated microglia in human neurological disorders. J. Neuropathol. Exp. Neurol. 67, 1001\u20131010 (2008).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"2103_CR44","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1177\/0271678X21992457","volume":"41","author":"B Ji","year":"2021","unstructured":"Ji, B. et al. Detection of Alzheimer\u2019s disease-related neuroinflammation by a PET ligand selective for glial versus vascular translocator protein. J. Cereb. Blood Flow Metab. 41, 2076\u20132089 (2021).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"2103_CR45","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.nbd.2018.09.022","volume":"121","author":"BB Tournier","year":"2019","unstructured":"Tournier, B. B. et al. TSPO and amyloid deposits in sub-regions of the hippocampus in the 3xTgAD mouse model of Alzheimer\u2019s disease. Neurobiol. Dis. 121, 95\u2013105 (2019).","journal-title":"Neurobiol. Dis."},{"key":"2103_CR46","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1177\/0271678X19860408","volume":"40","author":"BB Tournier","year":"2020","unstructured":"Tournier, B. B. et al. Fluorescence-activated cell sorting to reveal the cell origin of radioligand binding. J. Cereb. Blood Flow Metab. 40, 1242\u20131255 (2020).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"2103_CR47","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S1474-4422(20)30346-X","volume":"19","author":"WC Kreisl","year":"2020","unstructured":"Kreisl, W. C. et al. PET imaging of neuroinflammation in neurological disorders. Lancet Neurol. 19, 940\u2013950 (2020).","journal-title":"Lancet Neurol."},{"key":"2103_CR48","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","volume":"256","author":"RC Petersen","year":"2004","unstructured":"Petersen, R. C. Mild cognitive impairment as a diagnostic entity. J. Intern. Med. 256, 183\u2013194 (2004).","journal-title":"J. Intern. Med."},{"key":"2103_CR49","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann, G. M. et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 7, 263\u2013269 (2011).","journal-title":"Alzheimers Dement."},{"key":"2103_CR50","first-page":"130","volume":"10","author":"SC Johnson","year":"2018","unstructured":"Johnson, S. C. et al. The Wisconsin Registry for Alzheimer\u2019s Prevention: a review of findings and current directions. Alzheimers Dement. 10, 130\u2013142 (2018).","journal-title":"Alzheimers Dement."},{"key":"2103_CR51","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7","author":"MS Albert","year":"2011","unstructured":"Albert, M. S. et al. The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 7, 270\u2013279 (2011).","journal-title":"Alzheimers Dement."},{"key":"2103_CR52","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/jcbfm.2012.131","volume":"33","author":"WC Kreisl","year":"2013","unstructured":"Kreisl, W. C. et al. A genetic polymorphism for translocator protein 18 kDa affects both in vitro and in vivo radioligand binding in human brain to this putative biomarker of neuroinflammation. J. Cereb. Blood Flow Metab. 33, 53\u201358 (2013).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"2103_CR53","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S1474-4422(20)30071-5","volume":"19","author":"TK Karikari","year":"2020","unstructured":"Karikari, T. K. et al. Blood phosphorylated tau 181 as a biomarker for Alzheimer\u2019s disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. Lancet Neurol. 19, 422\u2013433 (2020).","journal-title":"Lancet Neurol."},{"key":"2103_CR54","doi-asserted-by":"crossref","first-page":"fcad057","DOI":"10.1093\/braincomms\/fcad057","volume":"5","author":"EM Jonaitis","year":"2023","unstructured":"Jonaitis, E. M. et al. Plasma phosphorylated tau 217 in preclinical Alzheimer\u2019s disease. Brain Commun. 5, fcad057 (2023).","journal-title":"Brain Commun."},{"key":"2103_CR55","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13195-023-01168-y","volume":"15","author":"SC Johnson","year":"2023","unstructured":"Johnson, S. C. et al. Identifying clinically useful biomarkers in neurodegenerative disease through a collaborative approach: the NeuroToolKit. Alzheimers Res. Ther. 15, 25 (2023).","journal-title":"Alzheimers Res. Ther."},{"key":"2103_CR56","doi-asserted-by":"crossref","unstructured":"Triana-Baltzer, G. et al. Development and validation of a high-sensitivity assay for measuring p217+tau in plasma. Alzheimers Dement. 13, e12204 (2021).","DOI":"10.1002\/dad2.12204"},{"key":"2103_CR57","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.exger.2019.04.003","volume":"121","author":"CS Jensen","year":"2019","unstructured":"Jensen, C. S. et al. Exercise as a potential modulator of inflammation in patients with Alzheimer\u2019s disease measured in cerebrospinal fluid and plasma. Exp. Gerontol. 121, 91\u201398 (2019).","journal-title":"Exp. Gerontol."},{"key":"2103_CR58","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/alz.12204","volume":"17","author":"C Van Hulle","year":"2021","unstructured":"Van Hulle, C. et al. An examination of a novel multipanel of CSF biomarkers in the Alzheimer\u2019s disease clinical and pathological continuum. Alzheimers Dement. 17, 431\u2013445 (2021).","journal-title":"Alzheimers Dement."},{"key":"2103_CR59","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nature11405","volume":"489","author":"MJ Hawrylycz","year":"2012","unstructured":"Hawrylycz, M. J. et al. An anatomically comprehensive atlas of the adult human brain transcriptome. Nature 489, 391\u2013399 (2012).","journal-title":"Nature"},{"key":"2103_CR60","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.neuroimage.2018.04.068","volume":"176","author":"G Gryglewski","year":"2018","unstructured":"Gryglewski, G. et al. Spatial analysis and high resolution mapping of the human whole-brain transcriptome for integrative analysis in neuroimaging. Neuroimage 176, 259\u2013267 (2018).","journal-title":"Neuroimage"},{"key":"2103_CR61","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13195-018-0402-y","volume":"10","author":"TA Pascoal","year":"2018","unstructured":"Pascoal, T. A. et al. In vivo quantification of neurofibrillary tangles with [18F]MK-6240. Alzheimers Res. Ther. 10, 74 (2018).","journal-title":"Alzheimers Res. Ther."},{"key":"2103_CR62","first-page":"S717","volume":"7","author":"V Fonov","year":"2011","unstructured":"Fonov, V., Coupe, P., Eskildsen, S. & Collins, D. P4-053: Atrophy specific MRI brain template for Alzheimer\u2019s disease and mild cognitive impairment. Alzheimers Dement. 7, S717 (2011).","journal-title":"Alzheimers Dement."},{"key":"2103_CR63","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2967\/jnumed.111.094029","volume":"53","author":"Z Cselenyi","year":"2012","unstructured":"Cselenyi, Z. et al. Clinical validation of 18F-AZD4694, an amyloid-\u03b2\u2212specific PET radioligand. J. Nucl. Med. 53, 415\u2013424 (2012).","journal-title":"J. Nucl. Med."},{"key":"2103_CR64","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fnins.2012.00171","volume":"6","author":"A Klein","year":"2012","unstructured":"Klein, A. & Tourville, J. 101 labeled brain images and a consistent human cortical labeling protocol. Front. Neurosci. 6, 171 (2012).","journal-title":"Front. Neurosci."},{"key":"2103_CR65","doi-asserted-by":"crossref","unstructured":"Jack, C. R. Jr et al. Defining imaging biomarker cut points for brain aging and Alzheimer\u2019s disease. Alzheimers Dement. 13, 205\u2013216 (2017).","DOI":"10.1016\/j.jalz.2016.08.005"},{"key":"2103_CR66","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2967\/jnumed.120.245209","volume":"62","author":"J Therriault","year":"2021","unstructured":"Therriault, J. et al. Determining amyloid-\u03b2 positivity using 18F-AZD4694 PET Imaging. J. Nucl. Med. 62, 247\u2013252 (2021).","journal-title":"J. Nucl. Med."},{"key":"2103_CR67","doi-asserted-by":"crossref","first-page":"614","DOI":"10.2967\/jnumed.120.245423","volume":"62","author":"VL Villemagne","year":"2021","unstructured":"Villemagne, V. L. et al. What is T+? A Gordian knot of tracers, thresholds, and topographies. J. Nucl. Med. 62, 614\u2013619 (2021).","journal-title":"J. Nucl. Med."},{"key":"2103_CR68","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.neurobiolaging.2013.09.028","volume":"35","author":"SC Johnson","year":"2014","unstructured":"Johnson, S. C. et al. Amyloid burden and neural function in people at risk for Alzheimer\u2019s disease. Neurobiol. Aging 35, 576\u2013584 (2014).","journal-title":"Neurobiol. Aging"},{"key":"2103_CR69","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1016\/j.neurobiolaging.2015.05.004","volume":"36","author":"KE Sprecher","year":"2015","unstructured":"Sprecher, K. E. et al. Amyloid burden is associated with self-reported sleep in nondemented late middle-aged adults. Neurobiol. Aging 36, 2568\u20132576 (2015).","journal-title":"Neurobiol. Aging"},{"key":"2103_CR70","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/nimg.2001.0978","volume":"15","author":"N Tzourio-Mazoyer","year":"2002","unstructured":"Tzourio-Mazoyer, N. et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15, 273\u2013289 (2002).","journal-title":"Neuroimage"},{"key":"2103_CR71","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1093\/brain\/awac213","volume":"145","author":"TJ Betthauser","year":"2022","unstructured":"Betthauser, T. J. et al. Multi-method investigation of factors influencing amyloid onset and impairment in three cohorts. Brain 145, 4065\u20134079 (2022).","journal-title":"Brain"},{"key":"2103_CR72","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/s41592-022-01625-w","volume":"19","author":"RD Markello","year":"2022","unstructured":"Markello, R. D. et al. neuromaps: structural and functional interpretation of brain maps. Nat. Methods 19, 1472\u20131479 (2022).","journal-title":"Nat. Methods"},{"key":"2103_CR73","doi-asserted-by":"crossref","first-page":"117038","DOI":"10.1016\/j.neuroimage.2020.117038","volume":"220","author":"JB Burt","year":"2020","unstructured":"Burt, J. B., Helmer, M., Shinn, M., Anticevic, A. & Murray, J. D. Generative modeling of brain maps with spatial autocorrelation. Neuroimage 220, 117038 (2020).","journal-title":"Neuroimage"},{"key":"2103_CR74","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fninf.2016.00020","volume":"10","author":"S Mathotaarachchi","year":"2016","unstructured":"Mathotaarachchi, S. et al. VoxelStats: a MATLAB package for multi-modal voxel-wise brain image analysis. Front. Neuroinform.10, 20 (2016).","journal-title":"Front. Neuroinform."},{"key":"2103_CR75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v048.i02","volume":"48","author":"Y Rosseel","year":"2012","unstructured":"Rosseel, Y. lavaan: an R package for structural equation modeling. J. Stat. Softw. 48, 1\u201336 (2012).","journal-title":"J. Stat. Softw."},{"key":"2103_CR76","doi-asserted-by":"crossref","unstructured":"Mueller, R. O. & Hancock, G. R. in Best Practices in Quantitative Methods (ed. Osborne, J.) 488\u2212508 (SAGE, 2008).","DOI":"10.4135\/9781412995627.d38"},{"key":"2103_CR77","first-page":"23","volume":"8","author":"K Schermelleh-Engel","year":"2003","unstructured":"Schermelleh-Engel, K., Moosbrugger, H. & M\u00fcller, H. Evaluating the fit of structural equation models: tests of significance and descriptive goodness-of-fit measures. Methods Psychol. Res. 8, 23\u201374 (2003).","journal-title":"Methods Psychol. Res."}],"container-title":["Nature Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41593-025-02103-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41593-025-02103-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41593-025-02103-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T14:32:36Z","timestamp":1767796356000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41593-025-02103-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["2103"],"URL":"https:\/\/doi.org\/10.1038\/s41593-025-02103-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5184011\/v1","asserted-by":"object"}]},"ISSN":["1097-6256","1546-1726"],"issn-type":[{"value":"1097-6256","type":"print"},{"value":"1546-1726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]},"assertion":[{"value":"30 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"W.V.B. served as a speaker for Novo Nordisk. J.T. has received personal fees from Alzheon and Neurotorium (outside the submitted work). S.G. is acting as scientist advisor to AmyriAD, Enigma USA, Eisai Canada, Lilly Canada, Novo Nordisk Canada and TauRx and is editor-in-chief of the\n                      Journal of Prevention of Alzheimer\n                      \u02bcs Disease\n                      . L.P.S. has participated in educational activities organized by Ach\u00e9, Apsen, Biogen, Knight, Libbs, Lilly, Novo Nordisk and Roche and has served on advisory boards for Biogen, Knight, Lilly, Novo Nordisk and Roche. G.T.-B. is an employee of Johnson & Johnson. H.C.K. was an employee of Johnson & Johnson at the time this work was performed. N.J.A. has given lectures in symposia sponsored by Lilly and Quanterix. H.Z. has served on scientific advisory boards and\/or as a consultant for AbbVie, Acumen, Alector, Alzinova, ALZPath, Amylyx, Annexon, Apellis, Artery Therapeutics, AZTherapies, Cognito Therapeutics, CogRx, Denali, Eisai, LabCorp, Merry Life, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics and Wave; has given lectures in symposia sponsored by Alzecure, Biogen, Cellectricon, Fujirebio, Lilly, Novo Nordisk and Roche; and is a co-founder of Brain Biomarker Solutions in Gothenburg AB, which is a part of the GU Ventures Incubator Program (outside the submitted work). K.B. has served as a consultant and on advisory boards for AbbVie, AC Immune, ALZPath, AriBio, BioArctic, Biogen, Eisai, Lilly, Moleac Pte. Ltd, Neurimmune, Novartis, Ono Pharmaceutical, Prothena, Roche Diagnostics and Siemens Healthineers; has served on data monitoring committees for Julius Clinical and Novartis; has given lectures, produced educational materials and participated in educational programs for AC Immune, Biogen, Celdara Medical, Eisai and Roche Diagnostics; and is a co-founder of Brain Biomarker Solutions in Gothenburg AB, which is a part of the GU Ventures Incubator Program (outside the submitted work). S.C.J. serves on advisory boards for ALZPath, Enigma Biomedical, Alamar, Lilly and Merck. E.R.Z. has served on scientific advisory boards, as a consultant or as a speaker for Nintx, Novo Nordisk, Biogen, Lilly and Magdalena Biosciences; he is also a co-founder and minority shareholder of masima. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}